BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7775115)

  • 1. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.
    Kernacki KA; Hobden JA; Hazlett LD; Fridman R; Berk RS
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1371-8. PubMed ID: 7775115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice.
    Kernacki KA; Fridman R; Hazlett LD; Lande MA; Berk RS
    Curr Eye Res; 1997 Apr; 16(4):289-97. PubMed ID: 9134316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye.
    Pillar CM; Hazlett LD; Hobden JA
    Curr Eye Res; 2000 Sep; 21(3):730-9. PubMed ID: 11120561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient.
    Estrellas PS; Alionte LG; Hobden JA
    Curr Eye Res; 2000 Mar; 20(3):157-65. PubMed ID: 10694889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial proteases and adherence of Pseudomonas aeruginosa to mouse cornea.
    Gupta SK; Masinick SA; Hobden JA; Berk RS; Hazlett LD
    Exp Eye Res; 1996 Jun; 62(6):641-50. PubMed ID: 8983946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases.
    Matsumoto K; Shams NB; Hanninen LA; Kenyon KR
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):1945-53. PubMed ID: 8491548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections.
    Steuhl KP; Döring G; Henni A; Thiel HJ; Botzenhart K
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1559-68. PubMed ID: 3305411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa proteases and corneal virulence.
    Hobden JA
    DNA Cell Biol; 2002; 21(5-6):391-6. PubMed ID: 12167241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
    McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Pseudomonas aeruginosa Small Protease (PASP), a Corneal Virulence Factor.
    Tang A; Caballero AR; Marquart ME; Bierdeman MA; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5993-6002. PubMed ID: 30572344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions.
    Marquart ME; Caballero AR; Chomnawang M; Thibodeaux BA; Twining SS; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3761-8. PubMed ID: 16186360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.
    Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD; McClellan S; Kwon B; Barrett R
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity.
    Thibodeaux BA; Caballero AR; Dajcs JJ; Marquart ME; Engel LS; O'Callaghan RJ
    Ocul Immunol Inflamm; 2005; 13(2-3):169-82. PubMed ID: 16019676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
    Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
    Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.